Elisabeth Sandoval, Chief Commercial Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 83,122 shares at $74.90 ($6.2M) on 2015-09-22, disclosed to the SEC on 2015-09-24.
Open-market sale of $6.2M KYTH by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.90 | 10,590 | $793K | 12.7% |
| 2 | $74.90 | 11,150 | $835K | 13.4% |
| 3 | $74.90 | 11,892 | $891K | 14.3% |
| 4 | $74.90 | 22,690 | $1.7M | 27.3% |
| 5 | $74.90 | 26,800 | $2.0M | 32.2% |
| Total | $74.90 avg | 83,122 |
| $6.2M |
| 100% |
| Filing → |